Keyword: Silk Road Medical
Stroke-prevention device maker Silk Road Medical has turned up its IPO to $120 million—well above its previous estimates of $86.25 million.
Silk Road Medical announced plans for an $86.25 million IPO on the Nasdaq, under the ticker symbol SILK.
The funding positions Silk Road to build on approvals and reimbursement nods it has picked up on both sides of the Atlantic for its TCAR devices.
Silk Road Medical is celebrating a positive reimbursement decision from Medicare for its transcarotid artery revascularization (TCAR) procedures. The news comes as music to Silk Road’s ears as it attempts to gain ground with its transcarotid neuroprotection and stent systems, which are used in the procedures.